PACB P/E Ratio
P/E Ratio as of Jul 1, 2025: -0.47
Average-0.4319
Median-0.4300
Minimum-0.5000
Maximum-0.3600
-0.47
Past Month-0.12 (34.29%)
The P/E ratio for PACB is -0.47 as of Jul 1, 2025. This represents a decrease of -52.53% compared to its 12-month average P/E ratio of -0.99. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Pacific Biosciences of California P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Pacific Biosciences of California’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pacific Biosciences of California to industry peers.
Pacific Biosciences of California P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Pacific Biosciences of California’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pacific Biosciences of California to industry peers.
PACB P/E Ratio Insights
See Pacific Biosciences of California’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PACB
Order type
Buy in
Order amount
Est. shares
0 shares
PACB P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $1.29 | -0.47 |
| Jun 2, 2025 | $0.9876 | -0.36 |
| May 1, 2025 | $1.11 | -0.68 |
| Apr 1, 2025 | $1.13 | -0.70 |
| Mar 3, 2025 | $1.315 | -1.16 |
| Feb 3, 2025 | $1.46 | -1.00 |
| Jan 2, 2025 | $1.80 | -1.24 |
PACB End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.47 | -62.70% |
| 2024 | -1.26 | -83.59% |
| 2023 | -7.68 | +25.90% |
| 2022 | -6.10 | -73.39% |
| 2021 | -22.92 | -107.41% |
| 2020 | 309.18 | — |
FAQs About Pacific Biosciences of California (PACB) P/E ratio
The latest P/E ratio of PACB is -0.47, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Pacific Biosciences of California’s last 12-month average P/E ratio is -0.99, compared to its current P/E ratio of -0.47. This reflects a decrease of -52.53%.
Pacific Biosciences of California’s current P/E ratio of -0.47 is lower than its last 12-month average P/E of -0.99. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Pacific Biosciences of California’s average P/E ratio over the last 3 years is -4.41. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Pacific Biosciences of California’s average P/E ratio over the last 5 years is -1.57. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.